John Apostol, MD | |
34503 9th Ave South, #220, Federal Way, WA 98003 | |
(253) 927-3243 | |
(253) 627-0855 |
Full Name | John Apostol |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 34503 9th Ave South, Federal Way, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174619274 | NPI | - | NPPES |
8375289 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD00042782 (Washington) | Primary |
Entity Name | Multicare Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Sanford Burnham Prebys Medical Discovery Institute is pleased to announce that Sumit Chanda, Ph.D., has received a $10.2 million, four-year grant from the Department of Defense to develop and advance broad-spectrum antivirals for respiratory diseases.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Toxicologists are revealing new methods and models for estimating infants' exposure to persistent organic pollutants (POPs) today at the Society of Toxicology (SOT) 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.
Ardea Biosciences, Inc. announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
In the first study of its kind, a drug-eluting stent (DES) with a biodegradable polymer applied only to the outer surface has been demonstrated as safe and effective as one of the most established and widely used types of DES with a durable polymer, in equivalent conditions to everyday clinical practice.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
John Apostol, MD 316 Martin Luther King Jr Way, #212, Tacoma, WA 98405 Ph: (253) 383-5777 | John Apostol, MD 34503 9th Ave South, #220, Federal Way, WA 98003 Ph: (253) 927-3243 |
News Archive
Sanford Burnham Prebys Medical Discovery Institute is pleased to announce that Sumit Chanda, Ph.D., has received a $10.2 million, four-year grant from the Department of Defense to develop and advance broad-spectrum antivirals for respiratory diseases.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Toxicologists are revealing new methods and models for estimating infants' exposure to persistent organic pollutants (POPs) today at the Society of Toxicology (SOT) 53rd Annual Meeting and ToxExpo in Phoenix, Ariz.
Ardea Biosciences, Inc. announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
In the first study of its kind, a drug-eluting stent (DES) with a biodegradable polymer applied only to the outer surface has been demonstrated as safe and effective as one of the most established and widely used types of DES with a durable polymer, in equivalent conditions to everyday clinical practice.
› Verified 6 days ago
Catherine Delostrinos, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 S 320th St, Federal Way, WA 98003 Phone: 253-874-7000 | |
Corrie L Takahashi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33501 1st Way S, Ms: A-so, Federal Way, WA 98003 Phone: 253-838-2400 Fax: 253-874-1637 | |
Pamela L. Mouser, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 S 320th St, Federal Way, WA 98003 Phone: 253-874-7000 | |
Deborah Ann Rodriguez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 34503 9th Ave South, #220, Federal Way, WA 98003 Phone: 253-927-3243 Fax: 253-627-0855 | |
Jonathan R Fox, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400 | |
Minh-y Ngoc Canh, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 33431 13th Pl S, Federal Way, WA 98003 Phone: 253-815-8040 |